Alan G. Roach

4.5k total citations
90 papers, 3.7k citations indexed

About

Alan G. Roach is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Physiology. According to data from OpenAlex, Alan G. Roach has authored 90 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Molecular Biology, 23 papers in Cellular and Molecular Neuroscience and 23 papers in Physiology. Recurrent topics in Alan G. Roach's work include Receptor Mechanisms and Signaling (33 papers), Nitric Oxide and Endothelin Effects (19 papers) and Neuropeptides and Animal Physiology (11 papers). Alan G. Roach is often cited by papers focused on Receptor Mechanisms and Signaling (33 papers), Nitric Oxide and Endothelin Effects (19 papers) and Neuropeptides and Animal Physiology (11 papers). Alan G. Roach collaborates with scholars based in United Kingdom, Netherlands and France. Alan G. Roach's co-authors include John C. Doxey, Icilio Cavero, Michael Day, Stéphane Berghmans, Paul Goldsmith, C. F. C. SMITH, Angeleen Fleming, W. Alderton, Anthony C. Lane and F Lefèvre-Borg and has published in prestigious journals such as Nature, Journal of Neuroscience and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Alan G. Roach

90 papers receiving 3.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alan G. Roach United Kingdom 33 1.7k 1.2k 631 623 393 90 3.7k
Daphné Atlas Israel 39 3.4k 2.0× 2.1k 1.7× 706 1.1× 920 1.5× 250 0.6× 155 5.0k
Morton Levitt United States 22 1.7k 1.0× 1.7k 1.4× 1.0k 1.6× 430 0.7× 237 0.6× 52 4.6k
Cyrus R. Creveling United States 35 2.2k 1.3× 1.4k 1.2× 561 0.9× 243 0.4× 158 0.4× 121 4.5k
R. Wayne Albers United States 37 3.2k 1.8× 1.1k 0.9× 669 1.1× 562 0.9× 212 0.5× 80 4.6k
Theodore W. Rall United States 28 3.7k 2.1× 1.6k 1.3× 1.4k 2.2× 559 0.9× 436 1.1× 49 6.8k
David Sugden United Kingdom 45 2.4k 1.4× 2.2k 1.8× 1.0k 1.6× 274 0.4× 208 0.5× 149 6.8k
Evald Rosengren Sweden 27 1.1k 0.6× 1.5k 1.2× 493 0.8× 396 0.6× 131 0.3× 63 3.6k
Alan Poisner United States 32 1.7k 1.0× 1.1k 0.9× 553 0.9× 384 0.6× 406 1.0× 113 3.6k
Bruce G. Livett Australia 38 3.3k 1.9× 2.6k 2.1× 886 1.4× 473 0.8× 173 0.4× 126 5.1k
Norman Kirshner United States 38 2.8k 1.6× 1.6k 1.3× 868 1.4× 966 1.6× 201 0.5× 112 4.7k

Countries citing papers authored by Alan G. Roach

Since Specialization
Citations

This map shows the geographic impact of Alan G. Roach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan G. Roach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan G. Roach more than expected).

Fields of papers citing papers by Alan G. Roach

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alan G. Roach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan G. Roach. The network helps show where Alan G. Roach may publish in the future.

Co-authorship network of co-authors of Alan G. Roach

This figure shows the co-authorship network connecting the top 25 collaborators of Alan G. Roach. A scholar is included among the top collaborators of Alan G. Roach based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alan G. Roach. Alan G. Roach is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Buckley, Clare E., Alan G. Roach, Paul Goldsmith, et al.. (2010). Drug reprofiling using zebrafish identifies novel compounds with potential pro-myelination effects. Neuropharmacology. 59(3). 149–159. 64 indexed citations
2.
Diekmann, Heike, Oleg Anichtchik, Angeleen Fleming, et al.. (2009). Decreased BDNF Levels Are a Major Contributor to the Embryonic Phenotype of Huntingtin Knockdown Zebrafish. Journal of Neuroscience. 29(5). 1343–1349. 69 indexed citations
3.
Anichtchik, Oleg, Heike Diekmann, Angeleen Fleming, et al.. (2008). Loss of PINK1 Function Affects Development and Results in Neurodegeneration in Zebrafish. Journal of Neuroscience. 28(33). 8199–8207. 133 indexed citations
4.
Barros, Teresa P., et al.. (2008). Zebrafish: an emerging technology for in vivo pharmacological assessment to identify potential safety liabilities in early drug discovery. British Journal of Pharmacology. 154(7). 1400–1413. 213 indexed citations
5.
Best, Jonathan D., et al.. (2007). Non-Associative Learning in Larval Zebrafish. Neuropsychopharmacology. 33(5). 1206–1215. 178 indexed citations
6.
Dyke, Hazel J., Peter Lockey, Dennis Norman, et al.. (2006). Quinazoline and benzimidazole MCH-1R antagonists. Bioorganic & Medicinal Chemistry Letters. 17(5). 1403–1407. 17 indexed citations
7.
Clark, David E., Hazel J. Dyke, Peter Lockey, et al.. (2004). Structure–activity relationships of a novel series of melanin-concentrating hormone (MCH) receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 14(15). 4099–4102. 36 indexed citations
8.
Broadley, Kenneth J., Kenneth L. Williamson, & Alan G. Roach. (1999). In vivo demonstration of α‐adrenoceptor‐mediated positive inotropy in pithed rats: evidence that noradrenaline does not stimulate myocardial α‐adrenoceptors. Journal of Autonomic Pharmacology. 19(1). 55–63. 13 indexed citations
9.
Chester, Adrian H., et al.. (1998). Atypical Antagonism Observed with BQ-123 in Human Saphenous Vein. Journal of Cardiovascular Pharmacology. 31. S172–S174. 6 indexed citations
10.
Jordan, Nicola, M. Watson, Robert J. Williams, et al.. (1997). Chemokine production by human vascular smooth muscle cells: modulation by IL‐13. British Journal of Pharmacology. 122(4). 749–757. 85 indexed citations
11.
Roach, Alan G., et al.. (1997). Evidence for Endothelin Involvement in the Pulmonary Vasoconstrictor Response to Systemic Hypoxia in the Isolated Rat Lung. Journal of Pharmacology and Experimental Therapeutics. 283(2). 419–425. 12 indexed citations
12.
Brown, Tom, et al.. (1997). In VitroExpression of Endothelin-1 (ET-1) and the ETAand ETBET Receptors by the Prostatic Epithelium and Stroma1. The Journal of Clinical Endocrinology & Metabolism. 82(2). 508–513. 25 indexed citations
13.
White, David G., et al.. (1993). The effect of NG‐nitro‐l‐arginine methyl ester upon basal blood flow and endothelium‐dependent vasodilatation in the dog hindlimb. British Journal of Pharmacology. 108(3). 763–768. 35 indexed citations
14.
Doxey, John C., et al.. (1992). Selectivity profile of the α2-adrenoceptor antagonist efaroxan in relation to plasma glucose and insulin levels in the rat. European Journal of Pharmacology. 213(2). 205–212. 14 indexed citations
15.
Doxey, John C., et al.. (1992). Comparison of the effects of efaroxan and glibenclamide on plasma glucose and insulin levels in rats. European Journal of Pharmacology. 213(2). 213–218. 21 indexed citations
16.
Williams, R. J., et al.. (1990). α2‐adrenoceptor antisecretory responses in the rat jejunum. Journal of Autonomic Pharmacology. 10(2). 109–118. 1 indexed citations
17.
Chapleo, Christopher B., David C. England, Peter L. Myers, et al.. (1989). Heteroaromatic analogs of the .alpha.2-adrenoreceptor partial agonist clonidine. Journal of Medicinal Chemistry. 32(7). 1627–1630. 15 indexed citations
18.
Chapleo, Christopher B., Anthony C. Lane, Malcolm Myers, et al.. (1988). Indoline analogs of idazoxan: potent .alpha.2-antagonists and .alpha.1-agonists. Journal of Medicinal Chemistry. 31(5). 944–948. 30 indexed citations
19.
Cavero, Icilio, et al.. (1979). Preliminary studies on SL 75212, a new potent cardioselective beta-adrenoceptor antagonist [proceedings].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 66(3). 445P–445P. 37 indexed citations
20.
Street, James A., B A Hemsworth, Alan G. Roach, & Michael Day. (1979). Tissue levels of several radiolabelled beta-adrenoceptor antagonists after intravenous administration in rats.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 237(2). 180–90. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Daphné Atlas Breakdown of academic impact, for papers by Morton Levitt Breakdown of academic impact, for papers by Cyrus R. Creveling Breakdown of academic impact, for papers by R. Wayne Albers Breakdown of academic impact, for papers by Theodore W. Rall Breakdown of academic impact, for papers by David Sugden Breakdown of academic impact, for papers by Evald Rosengren Breakdown of academic impact, for papers by Alan Poisner Breakdown of academic impact, for papers by Bruce G. Livett Breakdown of academic impact, for papers by Norman Kirshner
Rankless by CCL
2026